CAS No. |
14484-47-0 |
中文名称 |
2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-羟基-6a,8a,10-三甲基-4-氧代-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-十二氢-8bH-萘并[2',1':4,5]茚并[1,2-d]噁唑-8b-基)-2-氧代乙基乙酸酯 |
英文名称 |
2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-6a,8a,10-trimethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d]oxazol-8b-yl)-2-oxoethyl acetate |
别名 |
LS-13240 | DEFLAZACORT (MART.) | Deflazacort, United States Pharmacopeia (USP) Reference Standard | T70289 | Deflazacort (USAN/INN) | DTXSID9020378 | InChI=1/C3H5ClO/c1-2-3(4)5/h2H2,1H | Oxazacort | 2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-6a,8a,1 |
标准英文名 |
2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-6a,8a,10-trimethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d]oxazol-8b-yl)-2-oxoethyl acetate |
MDL No. |
MFCD00866106 |
分子式 |
C25H31NO6 |
分子量 |
441.52
|
精确分子量 |
441.22
|
SMILES |
CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C |
标准SMILES |
CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]21C |
用途 |
Deflazacort is a third-generation glucocorticoid with anti-inflammatory, anti-allergic, and gluconeogenesis-enhancing effects. It is used for primary and secondary adrenal insufficiency, rheumatic diseases, collagen diseases, dermatological conditions, allergic and hypersensitivity disorders, ophthalmic diseases, fulminant and disseminated tuberculosis (in combination with antitubercular drugs), hematologic disorders, ulcerative colitis, idiopathic nephrotic syndrome, and hematologic malignancies. |
InChIKey |
FBHSPRKOSMHSIF-GRMWVWQJSA-N |